. Author manuscript; available in PMC: 2021 Aug 9.

Published in final edited form as: J Am Coll Cardiol. 2018 Jan 23;71(3):306–317. doi: 10.1016/j.jacc.2017.11.020

Table 5:

ANOVA results from Changes in LVEF overtime by QRS group in Patients on GDMT

	Unadjusted (N=445)			Adjusted (N=444)
	Mean Change	Effect Estimate (95% CI)	ANOVA P-Value	LS Mean Change	Effect Estimate (95% CI)	ANOVA P-Value
LBBB	3.59 (±9.32)	-	<0.0001	2.02 (±14.12)	-	<0.0001
WQRS	5.05 (±9.24)	1.46 (2.98 to 5.89)		4.50 (±13.13)	2.48 (−1.90 to 6.86)
NQRS	10.19 (±12.11)	6.60 (3.73 to 9.46)		8.18 (±21.93)	6.15 (3.29 to 9.02)

Tukey Multiple Comparison Adjusted Analyses
Comparison	Unadjusted Tukey P-Value	Adjusted Tukey P-Value
LBBB vs. NQRS	<0.0001	<0.0001
LBBB vs. WQRS	0.7944	0.5068
NQRS vs. WQRS	0.0228	0.1242

Adjusted for: Baseline LVEF, Medical Therapy, History of Atrial Fibrillation/Flutter, Age, Gender, History of Cerebrovascular Disease (CVD), Prior Myocardial Infarction (MI), Baseline Heart Rate on ECG, History and Duration of Heart Failure, and Left Atrium Size; One patient excluded due to missing Heart Rate.